熱門資訊> 正文
Predictive Oncology宣布1比15反向股票拆分
2025-09-25 20:17
- Predictive Oncology (NASDAQ:POAI) on Thursday said it will effect a 1-for-15 reverse stock split of its issued and outstanding shares of common stock.
- Predictive Oncology’s common stock will continue to be traded on Nasdaq under the symbol POAI and will begin trading on a reverse split-adjusted basis when the market opens on September 30, 2025.
- The reverse stock split is primarily intended to bring the company into compliance with the minimum bid price requirement to maintain the listing of the company’s common stock on Nasdaq.
- Prior to the reverse stock split, the company had 11.43M shares of its common stock outstanding and immediately following the reverse stock split, there will be 762,414 shares of its common stock outstanding.
- POAI +0.84% premarket to $1.19.
- Source: Press Release
More on Predictive Oncology
- Financial information for Predictive Oncology
推薦文章
新股暗盤 | 滴普科技漲近50%，中籤一手賬面浮盈2660港元
新股暗盤 | 八馬茶業漲79.00%，中籤一手賬面浮盈3950港元
美股波動中的穩健長跑選手：華爾街押注Pinterest(PINS.US)、Uber(UBER.US)與通用汽車(GM.US)
黃金火爆行情帶熱招聘市場 對衝基金、貿易商高薪爭奪交易人才
迷霧中前行！美聯儲本周料將再度降息 內部分歧恐進一步加劇？
華盛早報 | 達成共識！貝森特「不再考慮」對中國加徵100%關税，美股三大股指期貨齊漲！賽力斯今起招股
新股申購 | 「首家A+H豪華新能源車企」賽力斯今起招股，一手入場費13282.62港元
港股周報 | 利好不斷！恆指重回26000點；高息股獲資金青睞！農業銀行錄得12連漲
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
